Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 10Neoplasms 3Fallopian Tube Neoplasms 3Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Prostatic Neoplasms 2Neoplasm Metastasis 2Brain Neoplasms 2Triple Negative Breast Neoplasms 1SCLC,Extensive Stage 1Rare Tumor 1Penile Neoplasms 1Pathologic Complete Response 1Pancreatic Adenocarcinoma Metastatic 1Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma 1Ovarian Carcinosarcoma 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Laryngeal Diseases 1Hemangiosarcoma 1Glioblastoma 1Endometrial Neoplasms 1Cystadenocarcinoma, Serous 1Carcinoma, Squamous Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Biliary Tract Neoplasms 1Advanced Solid Tumor 1

Interventions

Injections 12pembrolizumab 7toripalimab 6tislelizumab 5Oxaliplatin 3Gemcitabine 3Cisplatin 3Carboplatin 3trastuzumab deruxtecan 2spartalizumab 2lenvatinib 2atezolizumab 2Paclitaxel 2Nivolumab 2Immune Checkpoint Inhibitors 2Fulvestrant 2Fluorouracil 2Docetaxel 2Cyclophosphamide 2Cetuximab 2Bevacizumab 2Albumin-Bound Paclitaxel 2zimberelimab 1penpulimab 1olaparib 1niraparib 1nedaplatin 1fludarabine phosphate 1fludarabine 1enzalutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Advanced Solid Tumor × niraparib × Clear all
NCT06682780 2025-09-25

A Phase I/II Study of LM-2417 in Subjects With Advanced Solid Tumours

LaNova Medicines Limited

Phase 1/2 Recruiting
320 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡